MYXOFIBROSARCOMA
Clinical trials for MYXOFIBROSARCOMA explained in plain language.
Never miss a new study
Get alerted when new MYXOFIBROSARCOMA trials appear
Sign up with your email to follow new studies for MYXOFIBROSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Proton beams take aim at inoperable sarcomas in new norwegian trial
Disease control Recruiting nowThis study tests whether a higher dose of proton radiation can better control soft tissue sarcomas that cannot be surgically removed. About 40 adults in Norway will receive radiation over 4 weeks, with the highest dose focused on the tumor center. The main goal is to see if the t…
Matched conditions: MYXOFIBROSARCOMA
Phase: PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated May 26, 2026 05:45 UTC
-
Hope for rare childhood cancer: new drug combo aims to control soft tissue sarcoma
Disease control Recruiting nowThis study is for children and young adults (up to age 30) with a rare type of soft tissue cancer called non-rhabdomyosarcoma. The goal is to see if adding the targeted drug pazopanib (and another drug, selinexor, for high-risk patients) to standard chemotherapy and radiation can…
Matched conditions: MYXOFIBROSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 26, 2026 05:43 UTC
-
New combo therapy aims to delay sarcoma progression
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug pembrolizumab to a targeted chemotherapy infusion (ILI with melphalan and dactinomycin) can safely delay cancer growth in people with advanced sarcoma in an arm or leg. About 30 participants aged 12 and older will receive the…
Matched conditions: MYXOFIBROSARCOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 05:40 UTC